274
Participants
Start Date
April 25, 2019
Primary Completion Date
June 29, 2022
Study Completion Date
April 17, 2023
Bimekizumab
Subjects will receive bimekizumab at pre-specified time-points.
Placebo
Subjects will receive placebo at pre-specified time-points during the Double-Blind Treatment Period.
As0010 50020, Duncansville
As0010 50015, Hagerstown
As0010 50059, Ormond Beach
As0010 50056, Sarasota
As0010 50016, St Louis
As0010 50036, Mesquite
As0010 50057, Dallas
As0010 50052, Phoenix
As0010 50131, Mesa
As0010 50062, Sun City
As0010 50060, Upland
As0010 50061, Spokane
As0010 50055, Portland
As0010 50012, Memphis
As0010 40004, Brussels
As0010 40003, Genk
As0010 40001, Ghent
As0010 40002, Merksem
As0010 40006, Plovdiv
As0010 40007, Plovdiv
As0010 40005, Sofia
As0010 40008, Sofia
As0010 20040, Beijing
As0010 20021, Chengdu
As0010 20019, Guangzhou
As0010 20034, Hefei
As0010 20024, Nanjing
As0010 20018, Shanghai
As0010 20020, Shanghai
As0010 20026, Shanghai
As0010 20025, Wenzhou
As0010 40011, Brno
As0010 40009, Pardubice
As0010 40013, Prague
As0010 40014, Prague
As0010 40015, Prague
As0010 40016, Prague
As0010 40010, Uherské Hradiště
As0010 40012, Zlín
As0010 40018, Boulogne-Billancourt
As0010 40022, Limoges
As0010 40025, Berlin
As0010 40029, Hamburg
As0010 40024, Hanover
As0010 40027, Herne
As0010 40078, Leipzig
As0010 40026, Ratingen
As0010 40032, Debrecen
As0010 40031, Szeged
As0010 40033, Székesfehérvár
As0010 40080, Szombathely
As0010 20030, Chūōku
As0010 20039, Iruma-gun
As0010 20036, Kawachi-Nagano
As0010 20045, Kita-gun
As0010 20065, Kitakyushu
As0010 20038, Nankoku-shi
As0010 20037, Osaka
As0010 20084, Saga
As0010 20048, Saitama
As0010 20031, Sapporo
As0010 20035, Tokyo
As0010 40038, Elblag
As0010 40042, Krakow
As0010 40037, Lublin
As0010 40044, Poznan
As0010 40040, Torun
As0010 40041, Warsaw
As0010 40039, Wroclaw
As0010 40043, Wroclaw
As0010 40045, A Coruña
As0010 40046, Córdoba
As0010 40047, Madrid
As0010 40048, Santiago de Compostela
As0010 40049, Seville
As0010 40052, Ankara
As0010 40053, Ankara
As0010 40050, Istanbul
As0010 40051, Izmir
As0010 40057, Edinburgh
As0010 40056, Leeds
As0010 40054, London
As0010 40055, Norwich
UCB Biopharma SRL
INDUSTRY